In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent is better perceived by patients, the fragmented technology landscape sites have to navigate, the plain-language and health-literacy challenges baked into consent forms, and the timeline and budget pressures that keep eConsent from being standard practice. They also cover why pediatric and rare disease studies could be the fastest path to wider adoption, and how reconsent, an often-overlooked, recurring part of the process, is particularly well suited to going digital.
Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how...
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research...
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy...
